Research into vaccine safety has gained critical importance in recent years, particularly following the widespread deployment of COVID-19 vaccinations. Dual challenges have emerged, involving inadequate monitoring of adverse effects and insufficient compensation for those affected. These challenges
The Centers for Disease Control and Prevention (CDC) has recently faced considerable disruption, raising alarm and uncertainty across the spectrum of ongoing HIV research initiatives. The upheaval started with abrupt layoffs of several key HIV specialists, only to be followed by sudden
In an astonishing turn of events, the Bethesda Declaration by the National Institutes of Health (NIH) staff in Bethesda, Maryland, made waves amid ongoing political tensions. Set against the backdrop of dissent against policies introduced during Donald Trump’s presidency, the letter calls for a
The Trump administration is at a critical crossroads, facing a monumental decision on regulations designed during the Biden era to uphold mental health parity in insurance coverage. For nearly two decades, proponents of mental health parity have championed its realization, striving to ensure that
California's ambitious effort to transform mental health services in schools through the Children's and Youth Behavioral Health Initiative Fee Schedule Program has encountered significant hurdles, casting uncertainty over its rollout. Launched as part of a broader $4.7 billion initiative in 2021,
With the arrival of President Donald Trump's administration, the medical technology (medtech) industry faced a series of policy and regulatory transformations primarily steered by the U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS). These changes
